Pliant Therapeutics
PLRX
PLRX
61 hedge funds and large institutions have $648M invested in Pliant Therapeutics in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.81% more ownership
Funds ownership: 79.56% → 80.37% (+0.81%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
61
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$8.44M | |
| 2 | +$1.5M | |
| 3 | +$1.38M | |
| 4 |
Swiss National Bank
Zurich,
Switzerland
|
+$545K |
| 5 |
Goldman Sachs
New York
|
+$410K |
Top Sellers
| 1 | -$3.44M | |
| 2 | -$1.37M | |
| 3 | -$1.17M | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$566K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$526K |